Innovent expands global Phase 3 study of IBI363/TAK-928 to include non-squamous NSCLC

Akeso enrols first patient in global Phase III trial of cadonilimab vs nivolumab in first-line gastric cancer

Astellas doses first patient in Phase 3 lung cancer study

AstraZeneca's Trixeo Aerosphere approved in EU for asthma maintenance treatment

Insmed's ARIKAYCE sNDA granted priority review by FDA

Precigen announces FDA platform technology designation for AdenoVerse

Kelun-Biotech publishes phase III data for trastuzumab botidotin in HER2-positive breast cancer

GSK reports positive Jideytro data supporting potential first-line lung cancer use

Akeso presents positive results from registrational Phase III study of ivonescimab

Insilico Medicine doses first patient in Phase III trial of rentosertib

Altesa BioSciences presents positive vapendavir clinical data at ERS International Congress 2026

Clover Biopharmaceuticals reports positive Phase 2 trial data for respiratory combination vaccine candidates

Akeso's ivonescimab meets overall survival endpoint in interim analysis of Phase III HARMONi-2 study

AstraZeneca completes global licence agreement for Zegfrovy

Kazia Therapeutics reports 100% clinical benefit rate in initial paxalisib breast cancer trial